Action Required: Password Reset on Next Login
As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.
To reset your password, please visit the Reset Password page.
We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Pulmocide Ltd.
Headquarters: London, United Kingdom
Website: http://www.pulmocide.com
Year Founded: 2013
Status: Private
BioCentury | Jun 8, 2023
Management Tracks
New CFO, commercial officer at Pulmocide
Plus: Helmling named CBO at eTheRNA, and updates from EpimAb, Ring, Amarna, XNK and more
BioCentury | Dec 6, 2022
Data Byte
Pulmocide joins trio of start-ups with venture raises
Entact Bio, Vega mark debuts alongside $52M series C extension for U.K.’s Pulmocide
BioCentury | Sep 20, 2021
Finance
Closing Europe’s largest biotech fund at $630M, Jeito readies to build portfolio
French VC gearing up to build portfolio of European companies focused on severe diseases in small patient populations
BioCentury | Jun 11, 2021
Finance
Investment in Pulmocide pushes Jeito portfolio into the clinic and beyond cell and gene therapy
Firm leads $92M in U.K. respiratory play
BioCentury | Mar 25, 2017
Finance
Respiratory redux
Pulmocide management, investor experience attracted SR One to lead $30.4M round
Items per page:
1 - 10 of 11